Analysis of tumor biopsies from a PIK3CA-mutated metastatic breast cancer patient, enrolled on a study of alpelisib, has demonstrated the clinical relevance of progressive loss of PTEN expression and consequent gain of dependency on PI3K p110β isoform [351]. Here, PIK3CA is linked to neoplasm.